Serotype-specific patterns of reovirus disease in the CNS of newborn mice segregate with the viral S1 gene segment, which encodes attachment protein 1 and nonstructural protein 1s. The importance of receptor recognition in target cell selection by reovirus implicates the 1 protein as the primary effector of disease outcome. However, the contribution of 1s to reovirus disease is unknown. To define the function of 1s in reovirus pathogenesis, we generated a 1s-deficient virus by altering a single nucleotide to disrupt the 1s translational start site. Viruses were recovered that contain nine gene segments from strain type 3 Dearing and either the wild-type or 1s-null S1 gene segment from strain type 1 Lang. Following peroral inoculation of newborn mice, both viruses replicated in the intestine, although the wildtype virus achieved higher yields than the 1s-null virus. However, unlike the wild-type virus, the 1s-deficient virus failed to disseminate to sites of secondary viral replication, including the brain, heart, and liver. Within the small intestine, both viruses were detected in Peyer's patches, but only the wild-type virus reached the mesenteric lymph node. Concordantly, wild-type virus, but not 1s-deficient virus, was detected in the blood of infected animals. Wild-type and 1s-null viruses produced equivalent titers following intracranial inoculation, indicating that 1s is dispensable for viral growth in the murine CNS. These results suggest a key role for 1s in virus spread from intestinal lymphatics to the bloodstream, thereby allowing the establishment of viremia and dissemination to sites of secondary replication within the infected host.
V
iruses can disseminate from mucosal sites of inoculation to peripheral tissues to produce organ-specific disease (1) . Systemic dissemination requires that the virus effectively navigate diverse intracellular and extracellular environments to infect, replicate, and avoid immune detection and clearance in multiple cell and tissue types (1, 2) . However, viral factors that mediate dissemination within the infected host are largely unknown. This gap in knowledge has precluded development of therapeutics designed specifically to interrupt viral spread.
Mammalian orthoreoviruses (reoviruses) are highly tractable models for studies of viral replication and pathogenesis. Reoviruses are nonenveloped, icosahedral viruses that contain 10 segments of double-stranded (ds) RNA (3) . In newborn mice, reoviruses are highly virulent, causing injury to a variety of organs, including the central nervous system (CNS), heart, and liver (4) . Following oral or intramuscular inoculation, strains of serotype 1 (T1) and serotype 3 (T3) reovirus invade the CNS but use different routes and produce distinct diseases. T1 reovirus spreads hematogenously and infects ependymal cells, causing ependymitis and hydrocephalus (5) (6) (7) . In contrast, T3 reovirus spreads to the CNS by neural routes and infects neurons, causing lethal encephalitis (7, 8) . These differences segregate with the S1 dsRNA gene segment (9, 10) , which encodes viral attachment protein 1 and nonstructural protein 1s (11, 12) . Since receptor recognition dictates target cell selection by many viruses, these studies implicate the 1 attachment protein as the primary disease determinant. However, the contribution of 1s to reovirus pathogenesis has not been systematically defined.
The 1 ORF completely overlaps the 1s coding sequence; however, the two proteins lie in different reading frames (11, 13, 14) . Although little primary sequence identity exists between the 1s proteins of the three reovirus serotypes, the 1s ORF is retained by all strains sequenced to date (15) , suggesting that 1s performs an essential function in reovirus replication or transmission. The 14-kDa 1s protein is expressed at low levels during infection in cell culture and distributes to the nucleus and cytoplasm in infected cells (16) . Previous studies suggest that 1s is involved in reovirus-induced cell cycle arrest (17, 18) and apoptosis (19) .
In this study, we used reverse genetics to generate a 1s-deficient T1 reovirus comprised of nine gene segments from strain type 3 Dearing (T3D) in combination with the S1 allele from strain type 1 Lang (T1L) and compared this virus to wild-type virus following infection of cultured cells and mice. We found that the 1s-null mutant replicates with equivalent kinetics in cell culture and produces yields that approximate those of wild-type virus, indicating that the T1 1s protein is not required for reovirus replication. However, our studies reveal a critical role for 1s in reovirus pathogenesis. We found that 1s is required for reovirus spread from the site of inoculation to target organs. Although both wild-type and 1s-null viruses are taken up by Peyer's patches (PPs) in the intestine, only the wild-type virus replicates in the mesenteric lymph node (MLN) and invades the blood stream. These findings indicate that 1s is required for the establishment of viremia, which is essential for reovirus to access sites that support secondary viral replication in the host.
Results
Construction and Characterization of a 1s-Deficient Reovirus. To define the function of 1s in reovirus pathogenesis, we generated a recombinant reovirus incapable of expressing 1s using plasmid-based reverse genetics (20) (SI Text). The start codon for the 1s open reading frame was disrupted by introducing a single nucleotide change ( 75 AUG to 75 ACG) into the plasmid encoding the cDNA of the S1 gene segment derived from strain T1L (Fig.  1A) . Although this mutation alters the 1s translational start site, the primary amino acid sequence of the overlapping 1 open reading frame is unchanged. Viable viruses were recovered that contain nine gene segments from strain T3D and either the wild-type or 1s-null S1 gene from T1L (rsT3D/T1LS1 and rsT3D/T1LS1 1s-null, respectively). These viruses were gener-ated to facilitate studies to define the role of 1s in reovirus pathogenesis following peroral inoculation. The T3D 1 protein is cleaved and inactivated within the intestinal tract, whereas the T1L 1 protein is resistant to the intestinal proteases that cleave T3D 1 (21, 22) . Analysis of genomic dsRNA purified from virions of each virus verified that the rescued viruses contain the expected combination of gene segments (Fig. 1B) . The identity of the S1 gene segment and the integrity of the 1s translational start site from each virus were confirmed by direct sequencing of viral RNA. The S1 genes of both strains contained no additional mutations.
To confirm that alteration of the 1s translational start site prevents synthesis of the 1s protein, we assessed 1s expression by immunoblotting using T1L 1s-specific antiserum after infection of murine L929 cells with rsT3D/T1LS1 or rsT3D/T1LS1 1s-null (Fig. 1C) . At 24 h post-infection, 1s expression was detected in whole-cell lysates of cells infected with wild-type virus but not the 1s-null mutant. In parallel, blotting with reovirus-specific polyclonal antiserum showed equivalent steady state levels of viral proteins in cells infected with both viruses, suggesting a comparable level of infection by the wild-type and 1s-deficient strains. No differences in 1 protein levels were observed between the wild-type and mutant viruses, indicating that the single nucleotide change in the 1s-null mutant does not alter synthesis of the 1 protein. Thus, rsT3D/T1LS1 and rsT3D/T1LS1 1s-null are isogenic viruses that vary solely in 1s expression.
1s Is Not Required for Reovirus Replication in Cell Culture. To determine whether 1s influences T1 reovirus growth in cell culture, we quantified viral yields following infection of L929 cells (Fig. 2 ). At three MOIs tested, replication kinetics and yields of infectious progeny for the 1s-null virus were indistinguishable from those of wild-type virus. Plaque size of the 1s-null mutant and wild-type virus did not differ (Fig. S1 ). Following infection of HeLa cells and primary mouse embryo fibroblasts (MEFs), the 1s-deficient and wild-type viruses did not differ in replication kinetics or viral yields (Fig. S2 ). These results demonstrate that 1s is dispensable for T1 reovirus replication in cultured cells.
1s Is Required for Systemic Dissemination of Reovirus. To determine whether 1s influences reovirus pathogenesis, we inoculated newborn C57/BL6 mice perorally with 10 4 PFU of rsT3D/ T1LS1 or rsT3D/T1LS1 1s-null. At days 4, 8, and 12 postinoculation, we quantified viral titers in selected organs by plaque assay (Fig. 3A) . Both viruses replicated in the intestine, achieving peak titers in excess of 10 4 PFU per intestine. However, yields of wild-type virus were greater than those of the 1s-null mutant at each time point, suggesting that 1s enhances viral replication at that site. As anticipated, the wild-type virus produced detectable yields in spleen, liver, heart, and brain. In sharp contrast, the 1s-deficient virus was not detected at any site of secondary viral replication tested.
We thought it possible that the lower yields of virus in the intestine may be insufficient to allow the 1s-null virus to achieve a threshold required for systemic spread. To address this possibility, we inoculated newborn C57/BL6 mice perorally with a higher dose of virus, 10 6 PFU of rsT3D/T1LS1 or rsT3D/T1LS1 1s-null, and quantified viral yields in target organs (Fig. S3) . Even with a 100-fold increase in the inoculum, only a single animal of seven inoculated with rsT3D/T1LS1 1s-null harbored detectable virus in the liver, spleen, heart, and brain. Remarkably, the S1 gene sequence of virus recovered from those organs revealed that the disseminated virus had reverted from 75 ACG (mutant) to 75 AUG (wild-type), further underscoring the importance of 1s to reovirus pathogenesis. The 1s-null virus also did not produce detectable titer at sites of secondary viral replication following peroral inoculation of Swiss Webster ND4 mice (Fig. S4) , suggesting that the function of 1s is not restricted by the genetic background of the host. Thus, the 1s-deficient virus has an intrinsic defect that prevents either viral dissemination or viral growth in target tissues.
Although the 1s-null virus is capable of replication in the intestine (Fig. 3A) , we thought it possible that 1s expression may influence the types of cells infected in the gastrointestinal tract. To determine whether 1s dictates reovirus tropism in the intestine, we compared histologic sections of intestines from mice inoculated perorally with 10 7 PFU of rsT3D/T1LS1 or rsT3D/T1LS1 1s-null. Following infection with either wild-type or 1s-null virus, reovirus antigen was detected in columnar epithelial cells lining the intestinal villi (Fig. S5) . Reovirus antigen-positive cells localized primarily to the villus tips, with a small number of infected cells found in the intestinal crypts. These observations suggest that 1s does not alter the site of reovirus replication in the gastrointestinal tract.
1s Is Dispensable for Reovirus Growth in the Murine CNS. Failure to detect the 1s-null virus in peripheral organs following peroral inoculation suggests that 1s either facilitates delivery of reovirus to target tissues or is required for viral growth at sites of secondary replication. To distinguish between these possibilities, we inoculated newborn C57/BL6 mice intracranially with 100 PFU of rsT3D/T1LS1 or rsT3D/T1LS1 1s-null and determined viral titers in the brain at days 4, 8, and 12 post-inoculation (Fig.  3B) . Titers of wild-type and 1s-null viruses were equivalent at days 4 and 8 post-inoculation, indicating that 1s is not required for reovirus growth in the brain when virus is inoculated intracranially. Titers of the 1s-null virus were greater than those of wild-type virus at day 12 post-inoculation, perhaps reflecting enhanced clearance of wild-type virus from that site.
To determine whether 1s promotes spread of virus from the brain following intracranial infection, we inoculated newborn C57/ BL6 mice intracranially with 100 PFU of rsT3D/T1LS1 or rsT3D/ T1LS1 1s-null and determined viral titers in selected organs at days 4, 8, and 12 post-inoculation (Fig. S6 ). Similar to findings made in studies of mice inoculated perorally, yields of wild-type virus were markedly higher than those of 1s-deficient virus in each of the target sites tested. Wild-type virus was detected in the spleen, liver, heart, and intestine at all time points assessed. In contrast, the 1s-deficient virus was found only in the spleen at day 8 and intestine at day 12 and at titers significantly less than those produced by wild-type virus. Analysis of S1 gene sequences of virus isolates from peripheral organs of mice inoculated intracranially with 1s-null virus did not reveal reversion mutations, suggesting that 1s-deficient virus can disseminate from the brain, albeit with markedly diminished efficiency. Therefore, 1s substantially enhances systemic dissemination of reovirus regardless of the site of primary replication.
1s Enhances Virus Spread to the MLN and Is Required for Establishment of Viremia. Following peroral inoculation, reovirus is transcytosed by intestinal microfold (M) cells and infects underlying PPs. Virus is then thought to traffic via afferent lymphatics to the MLN and bloodstream, where it disseminates systemically. To determine whether 1s is required for reovirus dissemination within intestinal lymphatics, we inoculated newborn C57/BL6 mice perorally with 10 7 PFU of rsT3D/T1LS1 or rsT3D/T1LS1 1s-null and assessed PP cells for reovirus antigen (Fig. 4 A-D) and quantified reovirus titer in the MLNs (Fig. 4E) . Both the wild-type and 1s-null viruses were detected in mononuclear cells within PPs at days 1 and 3 post-inoculation (Fig. 4 A-D) . Although both viruses were capable of reaching the MLN at day 1 post-inoculation (Fig. 4E) , titers of wild-type virus were significantly greater than those of 1s-null virus at days 3 and 5 post-inoculation. These data indicate that 1s is not required for reovirus transport through intestinal lymphatics, but it may enhance virus growth once it reaches the MLN. We thought it possible that reduced titers of the 1s-null virus in the MLN might prevent establishment of viremia and hematogenous spread of reovirus to sites of secondary viral replication. To determine whether 1s is required for hematogenous dissemination, we inoculated newborn C57/BL6 mice perorally with 10 4 PFU of rsT3D/T1LS1 or rsT3D/T1LS1 1s-null and quantified virus titers in the blood at days 4, 8, and 12 postinoculation (Table 1) . Only wild-type virus was detectable in the blood of infected animals. The 1s-null virus was not found in the blood of any animal tested. Similar results were obtained when viral titers in blood were assessed following IC inoculation with 100 PFU of rsT3D/T1LS1 or rsT3D/T1LS1 1s-null (Table  S1 ). Thus, regardless of the route of inoculation, 1s is required by reovirus to establish viremia.
Discussion
Although nonstructural protein 1s is expressed by all three reovirus serotypes (13, 16, (23) (24) (25) , the role of 1s in reovirus replication and pathogenesis is not well defined. Database searches do not identify proteins with significant primary sequence similarity to 1s, and structural information about 1s is not available. Consequently, inferences about 1s function cannot be made by comparison to other proteins. Previous studies revealed that 1s is not required for reovirus replication in cell culture (16) and suggest a role for 1s in reovirus-induced cell cycle arrest (17, 18) , apoptosis (19) , and neurovirulence (19) . However, interpreting previous studies of 1s function is complicated by the use of a 1s-null mutant virus that is not isogenic to the parental strain from which the mutant was derived. The recent development of a reverse genetics system for reovirus (20) allowed us to generate a mutant reovirus that does not express 1s due to the introduction of a single nucleotide change that disrupts the translational initiation codon for the 1s ORF. The resulting 1s-null virus is viable, and single-cycle replication kinetics indicate that the 1s protein is dispensable for reovirus replication in cell culture. However, our studies indicate that 1s is required for reovirus spread from the point of inoculation to the bloodstream, which allows for viral dissemination to sites of secondary replication.
We envision three possibilities to explain how the 1s protein promotes reovirus dissemination. First, although our results clearly show that 1s is dispensable for reovirus growth in the intestine and brain (Fig. 3) , 1s may be required for viral replication in a cell type that is required for reovirus spread. For example, 1s may be essential for reovirus growth in leukocytes or other cell types required to transport reovirus to the blood. Second, 1s may antagonize the host response to reovirus infection. Many viruses encode nonstructural proteins that disrupt innate and adaptive defense mechanisms to evade immune detection and viral clearance. For example, rotavirus NSP1 antagonizes innate immune responses by mediating degradation of IFN-regulatory factors (26) . Human cytomegalovirus gene product US11 promotes destruction of MHC class I molecules to avoid detection of virus-infected cells by cytotoxic T lymphocytes (27) . If 1s counteracts one or more components of the host antiviral response, failure of the 1s-null virus to spread from the site of inoculation at early times following infection would suggest that innate immune mechanisms are a likely target, since the block to dissemination occurs before the onset of effector B-and T-cell responses. Third, 1s may be required for viral egress from infected cells. Although not incorporated into virions, 1s may be required for efficient release of infectious progeny. Nonstructural protein 3 (NS3) of bluetongue virus (BTV), another member of the Reoviridae, interacts with the host cell ESCRT machinery to facilitate BTV egress via a unique exocytic pathway (28, 29) . However, unlike NS3, 1s is not an integral membrane protein, and reovirus does not use a comparable egress pathway (28) (29) (30) . Although wildtype and 1s-null viruses do not differ in egress from cultured cells (SI Text and Fig. S1 ), it is possible that 1s is required for virus release from cells in vivo. * Newborn C57/BL6 mice were inoculated perorally with 10 4 PFU of rsT3D/ T1LS1 or rsT3D/T1LS1 1s-null. At 4, 8, and 12 days post-inoculation, mice were euthanized, blood was collected, and viral titers in blood were determined by plaque assay.
Previous studies have suggested a role for 1s in reovirusinduced cell cycle arrest at the G 2 /M boundary (17, 18) . However, it is not known whether reovirus induces cell cycle arrest in vivo or whether cell cycle dysregulation contributes to reovirus pathogenesis. In addition, 1s has been implicated in reovirusinduced apoptosis (19) . However, wild-type and 1s-null viruses do not display differences in apoptotic capacity in cultured cells (SI Text and Fig. S7 ). Algorithms that predict functional sites within proteins based on amino acid sequence similarities identify several potential interaction motifs within 1s for cellular proteins and a number of possible phosphorylation sites for cellular kinases (31) (32) (33) . Several of the potential 1s interacting partners identified by these searches are proteins associated with cell cycle regulation. Future experiments will focus on determining whether reovirus-induced cell cycle arrest contributes to reovirus pathogenesis.
Understanding mechanisms by which 1s enhances reovirus dissemination also may have important consequences for applications of reovirus as an oncolytic agent. Transformed cells are much more permissive for reovirus infection (34, 35) , and phase II clinical trials are underway to test reovirus as an adjunct to conventional cancer therapy (34, 36, 37) . The recently developed reverse genetics system for reovirus permits the design of reovirus-based therapeutics that incorporate mutations to enhance vector safety and efficacy (20) . Failure of the 1s-null virus to disseminate following either peroral or intracranial infection suggests that 1s-deficient reoviruses will remain localized to the site of inoculation regardless of the route of entry. While it is possible that viruses lacking 1s could be less effective at combating metastases due to failure to escape the site of primary replication, clinical use of 1s-deficient viruses could be an important safeguard to limit potential complications from this therapy.
In this study, we identified nonstructural protein 1s as a key viral determinant of reovirus pathogenesis that is required for the establishment of viremia and systemic dissemination. The capacity to spread systemically correlates with increased pathogenicity for many viruses, including influenza virus (38, 39) , severe acute respiratory syndrome coronavirus (40) , and poliovirus (41) . However, mechanisms that underlie systemic viral dissemination are largely unknown. Understanding how reovirus disseminates may inform studies of other viral pathogens capable of systemic spread and contribute to development of therapeutics designed specifically to interrupt this process.
Materials and Methods
Cells and Viruses. Murine L929 cells were maintained in Joklik's minimum essential medium (MEM) supplemented to contain 10% FBS, 2 mM Lglutamine (L-Glu), 100 U/mL penicillin, 100 g/mL streptomycin, and 25 ng/mL amphotericin B (Invitrogen). HeLa cells were maintained in DMEM (Invitrogen) supplemented to contain 10% FBS, 2 mM L-Glu, 100 U/mL penicillin, 100 g/mL streptomycin, and 25 ng/mL amphotericin B. MEFs were derived from C57/BL6 mice (42) and maintained in DMEM supplemented to contain 10% FBS, 1ϫ MEM nonessential amino acids (Invitrogen), 2 mM L-Glu, 0.1 mM 2-mercaptoethanol (Sigma), 20 mM HEPES, 100 U/mL penicillin, 100 g/mL streptomycin, and 0.25 g/mL amphotericin B. Cells at passages 4 -5 were used for the experiments in this study.
Recombinant reoviruses were generated as described in the SI Text. Purified reovirus virions were generated using second-or third-passage L-cell lysates stocks of twice-plaque-purified reovirus (43) . Viral particles were purified as described (44) . Viral titers were determined by plaque assay using L929 cells (45) . Electrophoretic mobility of viral dsRNA gene segments was verified using genomic dsRNA purified from CsCl-banded purified virions and 10% polyacrylamide gels (46) . Generation of Reovirus-Specific Antiserum. Rabbit polyclonal anti-1s serum was generated by Antibody Research Corporation. Two New Zealand white rabbits were immunized with a peptide corresponding to the C-terminal region of strain T1L 1s protein (DEHPLTRQMLEAYGQN) conjugated to keyhole limpet hemocyanin. Rabbits were immunized with peptide four times at 2-week intervals. Purified IgG was obtained by affinity purification with the immunizing peptide.
Rabbit polyclonal anti-1 serum was generated by Cocalico Biologicals. A single New Zealand white rabbit was immunized with the T1L 1 C-terminal head domain. Purification of the T1L 1 head domain is described in the SI Text. The rabbit was immunized with protein and boosted at 2, 3, and 7 weeks post-immunization.
Immunoblot Assay. Monolayers of L929 cells in 60-mm dishes (Corning) were either adsorbed with reovirus at an MOI of 100 PFU/cell or mock-infected at room temperature for 1 h in PBS, washed once with PBS, and incubated in serum-containing medium at 37°C. At 24 h post-adsorption, cells were lysed with 1ϫ RIPA buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Igepal, 0.1% SDS, 0.1% deoxycholate). Protein expression was assessed by SDS-PAGE and immunoblotting (47) using 1s-, 1-, or reovirus-specific polyclonal antiserum. Blots were visualized using an Odyssey infrared imaging system (LiCor Biosciences).
Virus Replication. Monolayers of cells in 24-well plates (Corning) were adsorbed in triplicate with reovirus at room temperature for 1 h in PBS, washed twice with PBS, and incubated at 37°C in serum-containing medium for various intervals. Cells were frozen and thawed twice before determination of viral titer by plaque assay using L929 cells (45) . Viral yields were calculated according to the following formula: Log10yieldtx ϭ log10(PFU/mL)tx -log10(PFU/ mL) t0, where tx is the time post-infection.
Infection of Mice. C57BL/6J mice were obtained from Jackson Laboratory, and Swiss-Webster ND4 mice were obtained from Harlan Biosciences. Newborn mice weighing 1.5-2 g were inoculated perorally or intracranially with purified reovirus diluted in PBS as described (42, 48, 49) . Blood was collected for analysis of viremia as described (42) . Viral titers in organ homogenates were determined by plaque assay (45) . For immunohistochemical analysis, mice were euthanized at various intervals post-inoculation, and organs were resected and fixed overnight in 10% formalin, followed by 70% ethanol. Fixed organs were embedded in paraffin, and 6-m histological sections were prepared. Sections were processed for detection of reovirus protein. Animal husbandry and experimental procedures were performed in accordance with Public Health Service policy and approved by the Vanderbilt University School of Medicine Institutional Animal Care and Use Committee.
Statistical Analysis. For experiments in which viral titers were determined in an organ or blood, the Mann-Whitney test was used to calculate two-tailed P values. This test is appropriate for experimental data that display a nonGaussian distribution (50) . When all values are less than the limit of detection, a Mann-Whitney test P value cannot be calculated. All statistical analyses were performed using Prism software (GraphPad Software).
